Oupeptide
Finnrick has tested 166 samples from Oupeptide across 8 products.
Take Action
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| Ipamorelin | 7 | 21 Aug 2025 | 26 Jan 2026 | |||||
| GHK-Cu | 10 | 14 Aug 2025 | 28 Apr 2026 | |||||
| BPC-157 | 8 | 15 Aug 2025 | 9 Feb 2026 | |||||
| Retatrutide | 59 | 9 Jun 2025 | 20 May 2026 | |||||
| Semaglutide | 6 | 5 Aug 2025 | 29 Jan 2026 | |||||
| Tesamorelin | 14 | 10 Aug 2025 | 28 Apr 2026 | |||||
| Tirzepatide | 61 | 3 Jun 2025 | 28 Apr 2026 | |||||
| PT-141 | 1 | 24 Jul 2025 | 24 Jul 2025 | |||||
The Oupeptide samples tested by Finnrick were either acquired by Finnrick directly, or submitted by the public.
Customer Reviews
These indicators of customer satisfaction are based on reports submitted by the public through the Finnrick testing program, and are not verified.
Based on 25 overall satisfaction reports
People who submitted test requests to Finnrick gave Oupeptide an average satisfaction rating of 4.4 out of 5 across 25 reports associated with samples received and tested by Finnrick.
Most recent Oupeptide tests
Samples are tested in commercial labs
tests
products
Scores
First
Last
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 20 May 2026 | Retatrutide | View | 20mg | 20.9mg | +4.5% | 99.90% | 3172026 | No label / Silver crimp / Violet cap | Lab E | Public | |
| 30 Apr 2026 | Retatrutide | View | 10mg | 9.6mg | -4.0% | 99.40% | 0U950 | Silver Label / Silver Crimp / Clear Blue Cap | Lab G | Public | |
| 28 Apr 2026 | GHK-Cu | View | 100mg | 81mg | -19.0% | 99.90% | (no batch ID) | No Label / Silver Crimp / Violet Cap | Lab E | Public | |
| 28 Apr 2026 | Tesamorelin | View | 10mg | 10.6mg | +6.0% | 99.90% | (no batch ID) | No Label / Silver Crimp / White Cap | Lab E | Public | |
| 28 Apr 2026 | Tirzepatide | View | 60mg | 55.7mg | -7.2% | 99.90% | (no batch ID) | No Label / Copper Crimp / Clear Cap | Lab E | Public | |
| 28 Apr 2026 | Retatrutide | View | 20mg | 21.1mg | +5.5% | 99.90% | (no batch ID) | No Label / Copper Crimp / Clear Cap | Lab E | Public | |
| 28 Apr 2026 | Retatrutide | View | 10mg | 9.84mg | -1.6% | 99.90% | (no batch ID) | No Label / Silver Crimp / Clear Blue Cap | Lab E | Public | |
Corrections
- 6 May 2026: Tesamorelin
- Data for sample hv46bd2 and f7qjrbk were swapped following a clerical error by Finnrick. On 6 May, the error was corrected.
- 6 May 2026: Retatrutide
- Data for sample 4z9e34c and 86nyk43 were swapped following a clerical error by Finnrick. On 6 May, the error was corrected.
About Oupeptide Test Results From Finnrick
Oupeptide is a peptide vendor with multiple products tracked in the independent testing dataset collected by Finnrick. This page compiles recent, batch-level test results across 8 products and 166 tests, including scores, test dates, batch IDs, and lab details. This enables you to compare quality over time, not just marketing claims.
Each tested sample receives a 0–10 score, with 10 being the best possible value. It is the total of three components: purity (0–4 points), quantity accuracy vs. the label or batch claim (0–4 points), and batch information quality (0–2 points).
When several test results are available for a product and vendor pair, you’ll also find a Finnrick Rating (A–E, where A is best and E is worst, X if an insufficient number of tests is available, or F in rare cases of documented and widespread fraud) and customer satisfaction reports with sub-scores that provide additional context. Use the table above to review purity, quantity accuracy, consistency between batches, and any notable outliers surfaced in Finnrick testing data.
Oupeptide Testing Activity & Score Summary
In the past 30 days, Finnrick has published no new test results for Oupeptide, and 8 in the past three months. The overall dataset includes 166 tested samples with an average score of 6.7/10 across all products.
Across 166 identity-tested samples, 98% were confirmed to contain the expected peptide (identity pass rate). Among those that passed, median purity was 99.8%. Approximately 96% of passing samples tested at or above 98% purity.
Here is a closer look at the most frequently tested products (top 3):
- Retatrutide (59 tests, 98% identity pass, median purity 99.8%) — Test scores are highly variable, ranging from 0.0 to 10.0 (average 7.2/10), suggesting significant batch-to-batch differences.
- Tirzepatide (61 tests, 98% identity pass, median purity 99.8%) — Test scores are highly variable, ranging from 0.0 to 10.0 (average 6.9/10), suggesting significant batch-to-batch differences.
- Tesamorelin (14 tests, 93% identity pass, median purity 99.0%) — Test scores are highly variable, ranging from 0.0 to 8.0 (average 5.4/10), suggesting significant batch-to-batch differences.